The MELD score predicts the short-term and overall survival after liver transplantation in patients with primary sclerosing cholangitis or autoimmune liver diseases

Langenbeck's Archives of Surgery

Volumn 399, Issue 8, 2014, Pages 1001-1009

  Hoffmann, Katrin ^a   Hinz, Ulf ^a   Hillebrand, Norbert ^a   Ganten, Tom ^b   Gotthardt, Daniel ^b   Longerich, Thomas ^c   Schirmacher, Peter ^c   Schemmer, Peter ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Department of Internal Medicine ^*  (Germany)

^c Institute of Pathology   (Germany)

Author keywords

Autoimmune hepatitis; Liver transplantation; Overlap syndrome; Primary sclerosing cholangitis

Indexed keywords

ADULT; AGED; ARTICLE; AUTOIMMUNE HEPATITIS; AUTOIMMUNE LIVER DISEASE; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KAPLAN MEIER METHOD; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; OVERALL SURVIVAL; OVERLAP SYNDROME; PREDICTION; PRIMARY SCLEROSING CHOLANGITIS; PROGNOSIS; RECURRENT DISEASE; RETROSPECTIVE STUDY; SHORT TERM SURVIVAL; SURGICAL TECHNIQUE; AUTOIMMUNE DISEASES; BIOPSY; CHOLANGITIS, SCLEROSING; LIVER DISEASES; MIDDLE AGED; MORTALITY; PREDICTIVE VALUE; SURVIVAL RATE;

ADULT; AUTOIMMUNE DISEASES; BIOPSY; CHOLANGITIS, SCLEROSING; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HUMANS; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84911985416     PISSN: 14352443     EISSN: 14352451     Source Type: Journal    
DOI: 10.1007/s00423-014-1237-z     Document Type: Article

References (32)

1. Bjoro K, Brandsaeter B, Foss A, Schrumpf E (2006) Liver transplantation in primary sclerosing cholangitis. Semin Liver Dis 26(1):69–79
2. Mottershead M, Neuberger J (2008) Transplantation in autoimmune liver diseases. World J Gastroenterol 14(21):3388–3395
3. Vogel A, Heinrich E, Bahr MJ et al (2004) Long-term outcome of liver transplantation for autoimmune hepatitis. Clin Transplant 18(1):62–69
4. Garcia CE, Garcia RF, Gunson B et al (2004) Analysis of marginal donor parameters in liver transplantation for primary biliary cirrhosis. Exp Clin Transplant 2:183–188
5. Silveira MG, Talwalkar JA, Angulo P, Lindor KD (2007) Overlap of autoimmune hepatitis and primary biliary cirrhosis: long-term outcomes. Am J Gastroenterol 102(6):1244–1250
6. Krawitt EL (2006) Autoimmune hepatitis. N Engl J Med 354(1):54–66
7. Kaplan MM, Gershwin ME (2005) Primary biliary cirrhosis. N Engl J Med 353(12):1261–1273
8. Eurotransplant International Foundation, Leiden, Netherlands. personal cummunication (2010)
9. Devlin J, O’Grady J (1999) Indications for referral and assessment in adult liver transplantation: a clinical guideline. Br Soc Gastroenterol Gut 45(Suppl 6):VI1–VI22
10. Mendes FD, Kim WR, Pedersen R, Therneau T, Lindor KD (2008) Mortality attributable to cholestatic liver disease in the United States. Hepatology 47(4):1241–1247
11. Graziadei IW, Wiesner RH, Marotta PJ et al (1999) Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis. Hepatology 30(5):1121–1127
12. Floreani A, Niro G, Rosa RE et al (2006) Type I autoimmune hepatitis: clinical course and outcome in an Italian multicentre study. Aliment Pharmacol Ther 24(7):1051–1057
13. Khalaf H, Mourad W, El-Sheikh Y et al (2007) Liver transplantation for autoimmune hepatitis: a single-center experience. Transplant Proc 39(4):1166–1170
14. Rust C, Beuers U (2008) Overlap syndromes among autoimmune liver diseases. World J Gastroenterol 14(21):3368–3373
15. Alvarez F, Berg PA, Bianchi FB et al (1999) International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31(5):929–938, 18
16. Belghiti J, Panis Y, Sauvanet A, Gayet B, Fekete F (1992) A new technique of side to side caval anastomosis during orthotopic hepatic transplantation without inferior vena caval occlusion. Surg Gynecol Obstet 175(3):270–272
17. Hoffmann K, Weigand M, Hillebrand N, Büchler MW, Schmidt J, Schemmer P (2009) Is veno-venous bypass still needed during liver transplantation? A review of the literature. Clin Transplant 23(1):1–8
18. Bruns H, Lozanovski VJ, Schultze D et al (2014) Prediction of postoperative mortality in liver transplantation in the era of MELD-based liver allocation: a multivariate analysis. PLoS ONE 9(6):e98782
19. Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213
20. A disease-based comparison of liver transplantation outcomes
21. Klose J, Klose MA, Metz C, et al. (2014) Outcome stagnation of liver transplantation for primary sclerosing cholangitis in the Model for End-Stage Liver Disease era. Langenbecks Arch Surg
22. Guo Z, He X, Wu L et al (2010) Model for end-stage liver disease versus the Child-Pugh score in predicting the post-transplant 3-month and 1-year mortality in a cohort of Chinese recipients. Surg Today 40(1):38–45
23. Forman LM, Lucey MR (2001) Predicting the prognosis of chronic liver disease: an evolution from child to MELD. Mayo end-stage liver disease. Hepatology 33(2):473–475
24. Weismuller TJ, Fikatas P, Schmidt J et al (2011) Multicentric evaluation of model for end-stage liver disease-based allocation and survival after liver transplantation in Germany—limitations of the ‘sickest first’-concept. Transpl Int 24(1):91–99
25. Bruns H, Hillebrand N, Schneider T et al (2011) LabMELD-based organ allocation increases total costs of liver transplantation: a single-center experience. Clin Transplant 25(5):E558–E565
26. David AI, Coelho MP, Paes AT et al (2012) Liver transplant outcome: a comparison between high and low MELD score recipients. Einstein Sao Paulo 10(1):57–61
27. Veit C, Bauer J, Döbler K, Eckert O, Woldenga C Qualität sichtbar machen. bqs-qualitätsreport 2007. BQS Bundesgeschäftsstelle Qualitätssicherung gGmbH 2008
28. Brandao A, Fuchs SC, Gleisner AL, Marroni C, Zanotelli ML, Cantisani G (2009) MELD and other predictors of survival after liver transplantation. Clin Transplant 23(2):220–227, 19
29. Bonney GK, Aldersley MA, Asthana S et al (2009) Donor risk index and MELD interactions in predicting long-term graft survival: a single-centre experience. Transplantation 87(12):1858–1863
30. Onaca NN, Levy MF, Sanchez EQ et al (2003) A correlation between the pretransplantation MELD score and mortality in the first two years after liver transplantation. Liver Transpl 9(2):117–123
31. Kamath PS, Kim WR (2007) The model for end-stage liver disease (MELD). Hepatology 45(3):797–805
32. Habib S, Berk B, Chang CC et al (2006) MELD and prediction of post-liver transplantation survival. Liver Transpl 12(3):440–447